LBS-007 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-12-31 in 3mo
ESTIMATED |
READOUT
The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Ac
Phase 1/2 · Relapsed or Resistant Acute Leukaemias |
Lin BioScience, Inc | LBS-007 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
|